Ono Pharmaceutical : Core profit rose despite lower revenue, driven by royalties and overseas growthQuartr·Jul 30 at 10:02 PM4528
Does Ono’s Expanding Oncology Pipeline and Qinlock Filing Reshape The Bull Case For Ono (TSE:4528)?Simplywall·Jul 9 at 10:54 AMOPHLY-2.31%4528
Ono Pharmaceutical (TSE:4528) Is Down 7.0% After Gastric Cancer Drug ONO-4578 Advances To Phase 3 – Has The Bull Case Changed?Simplywall·Jun 7 at 12:20 AMOPHLY-2.31%4528
Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual MeetingMorningStar·Jun 1 at 06:10 PM4528OPHLY-2.31%
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC)MorningStar·May 27 at 06:18 PMOPHLY-2.31%4528
Analyst Estimates: Here's What Brokers Think Of Ono Pharmaceutical Co., Ltd. (TSE:4528) After Its Yearly ReportSimplywall·May 12 at 05:01 PM4528OPHLY-2.31%
Ono Pharmaceutical (TSE:4528) Earnings Growth Versus Forecast Declines Tests Bull And Bear NarrativesSimplywall·May 9 at 05:04 PM4528
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With TagrissoTip Ranks·Mar 13 at 11:30 AMOPHLY-2.31%AZN-6.88%
Curatis and Neupharma sign development agreement for corticorelin in JapanPharmaceutical Technology·Mar 12 at 05:13 AM36714528
Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA ConferenceMorningStar·Mar 4 at 07:43 PM45284886
